Health Encyclopedia

Takayasu arteritis

Definition

Takayasu arteritis is an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body -- and its major branches.

Alternative Names

Pulseless disease

Causes, incidence, and risk factors

The cause of Takayasu arteritis is unknown. The disease occurs mainly in children and women younger than 30, especially those who are of Asian or African descent.

It appears to be an autoimmune condition, where immune cells are wrongly targeted against the body's own tissues, and it may involve other systems.

Symptoms

Arm weakness or pain with use
Chest pain
Dizziness
Fatigue
Fever
Light-headedness
Muscle or joint pain
Skin rash
Night sweats
Vision changes
Weight loss

Signs and tests

Decreased radial pulses (at the wrist)
Difference in blood pressure between the two arms
High blood pressure (hypertension)

There may also be signs of inflammation (pericarditis or pleuritis).

Tests:

Treatment

Treatment of Takayasu arteritis is difficult, but patients who do have the right treatment can see positive results. Early detection is important.

Most patients are treated with steroids and immunosuppressive drugs. Surgery is reserved for complications caused by narrowed arteries.

Surgery to bypass narrowed arteries -- angioplasty or stent placement -- may be needed to supply blood or open up the constriction.

Expectations (prognosis)

This disease can be fatal. However, with a combination of aggressive medical and surgical treatment, death rates have dropped dramatically.

In well-managed cases of Takayasu arteritis, the long-term survival rate is greater than 90%. The survival rate is better for adults than for children.

Complications

Blood clot
Heart attack
Heart failure
Pericarditis
Pleuritis
Stroke

Calling your health care provider

Call your health care provider if you have symptoms of this condition. Weak pulse, chest pain, and breathing difficulty require immediate care.

References

Maksimowicz-McKinnon K, Hoffman GS. Takayasu arteritis: what is the long-term prognosis? Rheum Dis Clin North Am. 2007;33:777-786.

Review Date:1/17/2008
Reviewed By:Neil J. Gonter, MD, Assistant Professor of Medicine, Columbia University, NY and private practice specializing in Rheumatology at Rheumatology Associates of North Jersey, Teaneck, NJ. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.